This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jw Pharmaceutical Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seiho Chin: Pharmaceutical Patent Inventor in Seoul
Introduction
Seiho Chin is an inventor based in Seoul, South Korea. His patent work concerns a crystalline form of a pharmaceutical compound and its potential use in treating skin conditions and related symptoms.
Latest Patents
Chin is associated with 1 patent: “Crystalline Form of 1-(8-Bromopyrido[2,3-E][1,2,4]triazolo[4,3-a]pyrazin-4-Yl)-N-methylazetidin-3-amine Hydrogen Sulfate Monohydrate.” The patent describes a novel polymorph of the compound, pharmaceutical compositions containing it, and its proposed use in treating atopic dermatitis, itch, pruritus, and forms of urticaria, including chronic idiopathic urticaria subtypes.
Career Highlights
Chin is associated with JW Pharmaceutical Corporation. His listed patent highlights work on the crystalline form of a pharmaceutical compound and its potential therapeutic applications.
Collaborations
Suha Park is identified as Chin’s coworker. The supplied information does not specify the nature of their collaboration on the patent.
Conclusion
Seiho Chin’s listed patent reflects pharmaceutical innovation focused on a compound’s crystalline form and its potential applications in treating dermatological conditions and related symptoms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile